BioLife Solutions, Inc. (BLFS) financial statements (2021 and earlier)

Company profile

Business Address 3303 MONTE VILLA PARKWAY
BOTHELL, WA 98021
State of Incorp. DE
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments909430662120
Cash and cash equivalents909430662120
Restricted cash and investments015     
Receivables8648544
Inventory, net of allowances, customer advances and progress billings121111111165
Inventory121111111165
Other undisclosed current assets5211110
Total current assets:1151284626243229
Noncurrent Assets
Finance lease, right-of-use asset0      
Operating lease, right-of-use asset10111111
Property, plant and equipment10555621
Long-term investments and receivables 000 16
Long-term investments 000 16
Intangible assets, net (including goodwill)89535455564514
Goodwill58343434342810
Intangible assets, net (excluding goodwill)3120212122164
Deposits noncurrent assets0000000
Other undisclosed noncurrent assets1197763 
Total noncurrent assets:120686869695223
TOTAL ASSETS:23519611495938452
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:4333342
Accounts payable4234321
Accrued liabilities0333310
Employee-related liabilities     21
Taxes payable0      
Other undisclosed accounts payable and accrued liabilities (2)(3)(4)(3)  
Deferred revenue1      
Debt1    11
Deferred compensation liability3      
Derivative instruments and hedges, liabilities32118   
Business combination, contingent consideration, liability3  0000
Other liabilities0      
Other undisclosed current liabilities13444  
Total current liabilities:168725853
Noncurrent Liabilities
Long-term debt and lease obligation9000111
Finance lease, liability0    00
Operating lease, liability9000111
Liabilities, other than long-term debt51114122
Other liabilities100 000
Business combination, contingent consideration, liability5001222
Derivative instruments and hedges, liabilities    40  
Total noncurrent liabilities:141124222
Total liabilities:3098274975
Stockholders' equity
Stockholders' equity attributable to parent20518710668437746
Common stock0000000
Additional paid in capital303282200145143137116
Accumulated deficit(97)(95)(94)(78)(100)(60)(70)
Total stockholders' equity:20518710668437746
TOTAL LIABILITIES AND EQUITY:23519611495938452

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues15111012877
Cost of revenue(8)(5)(4)(5)(3)(2)(2)
Cost of goods and services sold (5)(4)(5) (2)(2)
Gross profit:6658555
Operating expenses(10)(8)(7)(7)(6)(5)(4)
Other undisclosed operating income (loss)(2)010   
Operating income (loss):(5)(1)00(1)(1)1
Nonoperating income (expense)(1)0(16)22(13)10(0)
Investment income, nonoperating 100   
Interest and debt expense (0) (0) (0)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes0      
Income (loss) from continuing operations before equity method investments, income taxes:(5)(1)(16)22(14)91
Other undisclosed income (loss) from continuing operations before income taxes(0)0 0 00
Income (loss) from continuing operations before income taxes:(5)(1)(16)22(14)91
Other undisclosed income from continuing operations3   2  
Net income (loss) attributable to parent:(2)(1)(16)22(12)91
Other undisclosed net income (loss) available to common stockholders, basic0  (4)   
Net income (loss) available to common stockholders, basic:(2)(1)(16)18(12)91
Other undisclosed net income (loss) available to common stockholders, diluted1  (19)   
Net income (loss) available to common stockholders, diluted:(1)(1)(16)(0)(12)91

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net income (loss):(2)(1)(16)22(12)91
Comprehensive income (loss), net of tax, attributable to parent:(2)(1)(16)22(12)91

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: